CYTOSEN

WIPO WIPO 2019

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark CYTOSEN was filed as Word mark on 01/23/2019 at the World Intellectual Property Organization.

Trademark Details Last update: February 24, 2023

Trademark form Word mark
File reference 1477193
Countries Australia China European Community United Kingdom Japan South Korea
Base trademark US No. 88048354, July 23, 2018
Application date January 23, 2019
Expiration date July 6, 2020

Trademark owner

Paasheuvelweg 25A
1105 BP Amsterdam
NL

goods and services

05 Pharmaceutical preparations for the treatment of immuno oncological disorders, cancer, diabetes, respiratory, heart, neurological and auto immune disorders; stem cells for medical purposes; living cells for medical use; biological preparations for the treatment of cancer; therapeutics utilizing NC cells for use in the treatment of cancer, autoimmune disease and infectious diseases; cell preparations, cellular vaccines and cellular biologics for the treatment of cancer and infectious diseases by autologous cell-based immunotherapy
42 Scientific and technological services, namely, scientific research, design, analysis and testing in the field of cancer evolution and new cancer therapies using natural killer cells; industrial research in the field of new pharmaceutical products and new cancer therapies; medical and veterinary research services in the nature of the manipulation of cells within a laboratory or research facility to enable natural killer cells to be used for medical or therapeutic purposes; scientific research in the development of new cancer therapies; scientific research in human and animal cell therapy; scientific research into preparations for manipulating and adapting human and animal cells; consultancy relating to all the aforesaid services; conducting research and clinical trials for others relating to the use and the engineering of natural killer cells and cancer treatment and therapy; medical and scientific research in the field of cancer treatment and diagnosis; data collection for others for research purposes, namely, the collection, testing and research of patient molecular and genomic data; collection and preservation of human and animal DNA for research purposes
44 Medical testing for diagnostic or treatment purposes in the field of cancer research; medical diagnostic testing, monitoring and reporting services; medical evaluation of immuno oncological disorders, cancer, diabetes, respiratory, heart, neurological and auto immune disorders; medical monitoring services; medical diagnostic, prognostic and theranostic screening and testing services; collection and preservation of DNA for medical purposes; consulting services in the nature of providing medical information; consulting services in the field of healthcare and cancer diagnoses; providing health and healthcare information related to cancer, testing and screening via a website; genetic testing for medical purposes; providing information in the field of cancer prevention, screening, diagnosis and treatment for medical diagnostic and treatment purposes; providing genetics assessments in the nature of genetic counseling; genetic testing for medical diagnostic purposes; genomic testing for medical diagnostic purposes; gene analysis and sequencing and DNA analysis and sequencing for medical diagnostic purposes and veterinary diagnostics purposes; gene analysis and sequencing and DNA analysis and sequencing for use in cancer diagnosis and treatment; providing health and healthcare information related to cancer research, via a website

Trademark history

Date Document number Area Entry
March 9, 2021 2021/15 Gaz US RAW: Total Ceasing Effect
January 21, 2021 2021/5 Gaz KR Rejection
September 10, 2020 2020/37 Gaz JP Rejection
August 13, 2020 2020/33 Gaz KR Rejection
January 11, 2020 2020/3 Gaz AU Rejection
January 4, 2020 2020/2 Gaz GB Rejection
December 13, 2019 2019/51 Gaz EM Rejection
September 16, 2019 2019/40 Gaz CN Rejection
January 23, 2019 2019/26 Gaz US Registration

ID: 141477193